Your shopping cart is empty
Subscriber login
REGISTER FOR FREE EZINES
Advanced Search
- Please Select -
Return to the main site
Regulation
Business Development
Drug Manufacturing
Device Manufacturing
Quality Management
Return to the main site
Home
Books
Conferences
DVDs
Newsletters
Form 483
s
Pharma Quality Advisor
Webinar Training Pass
White Papers
Advertising/Sponsorships
About Us
Check out our free and informative ezines and sign up now
Sign Up
Home
>
Newsletters
>
FDAnews Device Daily Bulletin
> J&J Q3 Earnings Dip on Manufacturing Issues
FDAnews Device Daily Bulletin
Dec. 9, 2011
| Vol. 8 No. 240
J&J Q3 Earnings Dip on Manufacturing Issues
Diversion of resources from marketing and research to quality and manufacturing figured into a domestic sales slump and a 6 percent drop in earnings at Johnson & Johnson (J&J) in the third quarter from the same period in 2010.
The GMP Letter
Register Now
Print This Page
Email This Article
RSS
Archives
Related Articles
Health Affects Benefits of Implanted Heart Device
Trove of Medical Devices Found to Have Password Problems
Delcath Faces Investor Ire Following Negative FDA Panel Vote
Boston Scientific Begins Patient Enrollment in U.S. Clinical Trial for Use of Vercise DBS System for Parkinson's Disease